Trade BNGO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bionano Genomics, Inc. (BNGO) is trading at US$1.18, down 1.67% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$14.13M. Over the past 52 weeks, BNGO has traded between US$1.00 and US$5.50. On Syfe you can trade BNGO with $0 commission and add it to your watchlist.
| Previous close | US$1.20 |
|---|---|
| Market cap | US$14.13M |
| 52-week range | US$1.00 – US$5.50 |
| Volume | 69.34K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bionano Genomics, Inc.
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Year: 2018
Bionano Genomics, Inc. (BNGO) stock is trading at US$1.18, -1.67% from the previous close of US$1.20.
The market cap for Bionano Genomics, Inc. (BNGO) stock is approximately US$14.13M.
The 52-week high for Bionano Genomics, Inc. (BNGO) stock is US$5.50.
The 52-week low for Bionano Genomics, Inc. (BNGO) stock is US$1.00.
Bionano Genomics, Inc. (BNGO) does not currently pay a dividend.
Stay on top of BNGO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
